CONMED Operating Income from 2010 to 2026

CNMD Stock

USD 41.80 0.13 0.31%

CONMED's Operating Income is increasing over the years with slightly volatile fluctuation. Overall, Operating Income is expected to go to about 136.6 M this year. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit CONMED generates from its operations. View All Fundamentals

Operating Income

First Reported

1986-03-31

Previous Quarter

11.9 M

Current Value

46.3 M

Quarterly Volatility

13.2 M

Black Monday

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Interest Hikes

Check CONMED financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CONMED's main balance sheet or income statement drivers, such as Depreciation And Amortization of 78 M, Interest Expense of 32.6 M or Selling General Administrative of 548.2 M, as well as many indicators such as Price To Sales Ratio of 0.98, Dividend Yield of 0.0138 or PTB Ratio of 1.3. CONMED financial statements analysis is a perfect complement when working with CONMED Valuation or Volatility modules.

Build AI portfolio with CONMED Stock

Check out the analysis of CONMED Correlation against competitors.

For information on how to trade CONMED Stock refer to our How to Trade CONMED Stock guide.

Analyzing CONMED's Operating Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Operating Income has evolved provides context for assessing CONMED's current valuation and future prospects.

Latest CONMED's Operating Income Growth Pattern

Below is the plot of the Operating Income of CONMED over the last few years. Operating Income is the amount of profit realized from CONMED operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of CONMED is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. CONMED's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CONMED's overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Operating Income

Timeline

CONMED Operating Income Regression Statistics

	Arithmetic Mean	75,520,785
	Geometric Mean	52,497,509
	Coefficient Of Variation	66.43
	Mean Deviation	38,046,546
	Median	65,210,000
	Standard Deviation	50,167,813
	Sample Variance	2516.8T
	Range	198.9M
	R-Value	0.83
	Mean Square Error	840.4T
	R-Squared	0.69
	Significance	0.000039
	Slope	8,234,200
	Total Sum of Squares	40269T

CONMED Operating Income History

	2026	136.6 M
	2025	130.1 M
	2024	200.3 M
	2023	120.6 M
	2022	70.1 M
	2021	109.7 M
	2020	46 M

Other Fundumenentals of CONMED

Non Operating Income Net Other

CONMED Operating Income component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Good Will	Common Stock	Long Term Debt	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.94	0.95	0.87	0.96	0.98	0.96	0.09	0.98	0.96	0.98	-0.43	0.89	0.42	0.31	-0.03	-0.92	0.96	0.85	-0.68	0.23	0.87	0.78	-0.57
Total Stockholder Equity	0.94		0.81	0.97	0.98	0.87	0.97	-0.04	0.89	0.91	0.88	-0.23	0.72	0.23	0.53	-0.12	-0.76	0.83	0.73	-0.54	0.02	0.74	0.72	-0.62
Net Debt	0.95	0.81		0.72	0.86	0.98	0.84	0.17	0.97	0.92	0.99	-0.61	0.98	0.53	0.04	0.15	-0.98	0.99	0.89	-0.8	0.36	0.89	0.75	-0.48
Retained Earnings	0.87	0.97	0.72		0.94	0.78	0.9	-0.08	0.83	0.83	0.79	-0.22	0.61	0.02	0.59	-0.01	-0.65	0.73	0.61	-0.44	-0.01	0.6	0.59	-0.57
Net Receivables	0.96	0.98	0.86	0.94		0.91	0.96	0.0	0.93	0.93	0.91	-0.32	0.78	0.27	0.45	-0.08	-0.82	0.87	0.76	-0.61	0.06	0.77	0.72	-0.58
Total Liab	0.98	0.87	0.98	0.78	0.91		0.91	0.15	0.98	0.94	0.99	-0.51	0.94	0.49	0.18	0.02	-0.97	0.98	0.88	-0.73	0.33	0.9	0.77	-0.52
Total Current Assets	0.96	0.97	0.84	0.9	0.96	0.91		0.02	0.91	0.93	0.91	-0.25	0.77	0.36	0.47	-0.22	-0.81	0.86	0.78	-0.55	0.1	0.82	0.78	-0.62
Short Term Debt	0.09	-0.04	0.17	-0.08	0.0	0.15	0.02		0.12	-0.06	0.11	0.02	0.07	0.02	0.05	0.13	-0.14	0.06	0.09	-0.28	0.77	0.07	-0.1	0.24
Intangible Assets	0.98	0.89	0.97	0.83	0.93	0.98	0.91	0.12		0.93	0.97	-0.52	0.91	0.36	0.23	0.07	-0.94	0.96	0.83	-0.68	0.32	0.84	0.72	-0.51
Accounts Payable	0.96	0.91	0.92	0.83	0.93	0.94	0.93	-0.06	0.93		0.96	-0.51	0.91	0.54	0.18	-0.06	-0.9	0.95	0.86	-0.69	0.08	0.89	0.85	-0.67
Good Will	0.98	0.88	0.99	0.79	0.91	0.99	0.91	0.11	0.97	0.96		-0.53	0.96	0.54	0.14	0.04	-0.96	0.99	0.9	-0.77	0.26	0.91	0.8	-0.56
Common Stock	-0.43	-0.23	-0.61	-0.22	-0.32	-0.51	-0.25	0.02	-0.52	-0.51	-0.53		-0.69	-0.4	0.57	-0.67	0.63	-0.62	-0.51	0.57	-0.29	-0.46	-0.37	0.19
Long Term Debt	0.89	0.72	0.98	0.61	0.78	0.94	0.77	0.07	0.91	0.91	0.96	-0.69		0.66	-0.13	0.14	-0.97	0.98	0.89	-0.8	0.31	0.91	0.77	-0.52
Treasury Stock	0.42	0.23	0.53	0.02	0.27	0.49	0.36	0.02	0.36	0.54	0.54	-0.4	0.66		-0.47	-0.19	-0.57	0.57	0.65	-0.62	0.11	0.71	0.68	-0.4
Property Plant Equipment	0.31	0.53	0.04	0.59	0.45	0.18	0.47	0.05	0.23	0.18	0.14	0.57	-0.13	-0.47		-0.46	0.02	0.03	0.0	0.25	-0.15	0.02	0.07	-0.21
Current Deferred Revenue	-0.03	-0.12	0.15	-0.01	-0.08	0.02	-0.22	0.13	0.07	-0.06	0.04	-0.67	0.14	-0.19	-0.46		-0.1	0.09	0.04	-0.27	0.32	-0.11	-0.24	0.24
Net Tangible Assets	-0.92	-0.76	-0.98	-0.65	-0.82	-0.97	-0.81	-0.14	-0.94	-0.9	-0.96	0.63	-0.97	-0.57	0.02	-0.1		-0.98	-0.89	0.77	-0.35	-0.91	-0.78	0.39
Long Term Debt Total	0.96	0.83	0.99	0.73	0.87	0.98	0.86	0.06	0.96	0.95	0.99	-0.62	0.98	0.57	0.03	0.09	-0.98		0.9	-0.77	0.27	0.91	0.79	-0.55
Capital Surpluse	0.85	0.73	0.89	0.61	0.76	0.88	0.78	0.09	0.83	0.86	0.9	-0.51	0.89	0.65	0.0	0.04	-0.89	0.9		-0.81	0.23	0.98	0.91	-0.38
Deferred Long Term Liab	-0.68	-0.54	-0.8	-0.44	-0.61	-0.73	-0.55	-0.28	-0.68	-0.69	-0.77	0.57	-0.8	-0.62	0.25	-0.27	0.77	-0.77	-0.81		-0.32	-0.77	-0.64	0.28
Short Long Term Debt	0.23	0.02	0.36	-0.01	0.06	0.33	0.1	0.77	0.32	0.08	0.26	-0.29	0.31	0.11	-0.15	0.32	-0.35	0.27	0.23	-0.32		0.2	0.01	0.19
Net Invested Capital	0.87	0.74	0.89	0.6	0.77	0.9	0.82	0.07	0.84	0.89	0.91	-0.46	0.91	0.71	0.02	-0.11	-0.91	0.91	0.98	-0.77	0.2		0.93	-0.44
Net Working Capital	0.78	0.72	0.75	0.59	0.72	0.77	0.78	-0.1	0.72	0.85	0.8	-0.37	0.77	0.68	0.07	-0.24	-0.78	0.79	0.91	-0.64	0.01	0.93		-0.45
Capital Stock	-0.57	-0.62	-0.48	-0.57	-0.58	-0.52	-0.62	0.24	-0.51	-0.67	-0.56	0.19	-0.52	-0.4	-0.21	0.24	0.39	-0.55	-0.38	0.28	0.19	-0.44	-0.45

Click cells to compare fundamentals

About CONMED Financial Statements

CONMED stakeholders use historical fundamental indicators, such as CONMED's Operating Income, to determine how well the company is positioned to perform in the future. Although CONMED investors may analyze each financial statement separately, they are all interrelated. For example, changes in CONMED's assets and liabilities are reflected in the revenues and expenses on CONMED's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in CONMED. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Operating Income	130.1 M	136.6 M
Non Operating Income Net Other	-100.8 M	-95.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

FSLY	Fastly Class A
MOB	Mobilicom Limited American
CMG	Chipotle Mexican Grill

When determining whether CONMED is a strong investment it is important to analyze CONMED's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CONMED's future performance. For an informed investment choice regarding CONMED Stock, refer to the following important reports:

How To Invest In CONMED

Details

Is CONMED Stock a good investment?

Details

What is CONMED's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of CONMED Correlation against competitors.

For information on how to trade CONMED Stock refer to our How to Trade CONMED Stock guide.

You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Will Health Care Equipment & Supplies sector continue expanding? Could CONMED diversify its offerings? Factors like these will boost the valuation of CONMED. Projected growth potential of CONMED fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every CONMED data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.

Quarterly Earnings Growth

(0.50)

Dividend Share

0.6

Earnings Share

1.51

Revenue Per Share

44.294

Quarterly Revenue Growth

0.079

CONMED's market price often diverges from its book value, the accounting figure shown on CONMED's balance sheet. Smart investors calculate CONMED's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since CONMED's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.

It's important to distinguish between CONMED's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CONMED should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, CONMED's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

CONMED Operating Income from 2010 to 2026

Latest CONMED's Operating Income Growth Pattern

CONMED Operating Income Regression Statistics

CONMED Operating Income History

Other Fundumenentals of CONMED

CONMED Operating Income component correlations

About CONMED Financial Statements

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY